Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RE-ALIGN Extension
NL-OMON39208Phase 2Active, not recruiting
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of dabigatran and warfarin in mechanical heart valve (2 arms), sponsored by Boehringer Ingelheim. Started Jun 2012; status: active, not recruiting.
02
Drugs
dabigatranwarfarin
03
Conditions
mechanical heart valve
Beyond the preview
Go deeper on NL-OMON39208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39208.